Trimethoprim Capsule

Trimethoprim Capsules exert a potent bacteriostatic effect by selectively inhibiting bacterial dihydrofolate reductase, a critical mechanism that disrupts the folic acid synthesis pathway essential for microbial DNA production. The capsule delivery system is specifically engineered for rapid gastric disintegration and high oral bioavailability, ensuring predictable pharmacokinetic profiles and consistent therapeutic concentrations at the primary site of infection. This optimized oral formulation enhances patient compliance through ease of administration while providing a clinically robust solution for the targeted management of acute urinary tract infections and susceptible respiratory pathologies.